🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,03 USD

Máx. histórico

108,06

1029 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,60%

Rango 52 semanas

58,05 – 88,31

Variación hoy

-1,52%

Cierre anterior

62,99

Rango de hoy

61,97 – 64,00

Volumen hoy

1.559.905

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,38%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 23 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/11/2025 66,01 67,98 65,33 66,95 +0,77% 4,01% 2.392.600
14/11/2025 64,11 67,07 64,11 66,44 +1,40% 4,62% 2.150.600
13/11/2025 65,28 65,92 64,31 65,52 -0,64% 2,47% 2.313.700
12/11/2025 66,51 66,98 65,07 65,94 -0,84% 2,87% 2.468.800
11/11/2025 62,16 66,72 61,66 66,50 +6,91% 8,14% 2.417.400
10/11/2025 60,30 62,84 60,01 62,20 +3,39% 4,69% 1.795.700
07/11/2025 60,20 60,36 58,25 60,16 -0,23% 3,50% 1.881.300
06/11/2025 58,85 61,29 58,05 60,30 +1,88% 5,51% 2.204.600
05/11/2025 59,34 60,43 58,61 59,19 -0,72% 3,07% 1.320.800
04/11/2025 59,55 60,77 58,95 59,62 -0,68% 3,06% 979.000
03/11/2025 63,49 63,96 59,11 60,03 -5,60% 7,64% 2.142.700
31/10/2025 63,14 63,99 61,69 63,59 +2,15% 3,64% 2.430.200
30/10/2025 61,54 64,13 61,49 62,25 +0,42% 4,29% 1.542.100
29/10/2025 62,01 63,22 61,01 61,99 +0,03% 3,56% 1.912.300
28/10/2025 59,88 62,15 59,52 61,97 +2,97% 4,39% 1.939.400
27/10/2025 58,10 60,78 57,83 60,18 +4,06% 5,08% 1.461.800
24/10/2025 57,99 58,36 56,98 57,83 +0,57% 2,38% 1.067.000
23/10/2025 55,49 58,05 54,30 57,50 +5,00% 6,76% 1.891.000
22/10/2025 57,78 57,78 54,46 54,76 -5,23% 5,75% 2.659.100
21/10/2025 59,42 59,47 57,66 57,78 -2,65% 3,05% 1.081.700
20/10/2025 59,11 60,00 58,44 59,35 +1,56% 2,64% 1.381.800
17/10/2025 58,04 59,89 57,51 58,44 -0,88% 4,10% 1.162.000
16/10/2025 62,94 63,58 58,40 58,96 -6,11% 8,23% 2.138.300
15/10/2025 61,03 63,86 61,00 62,80 +2,90% 4,69% 2.043.700
14/10/2025 59,05 61,58 58,84 61,03 +2,42% 4,64% 2.173.700
13/10/2025 60,04 61,14 59,46 59,59 -0,75% 2,80% 1.379.400
10/10/2025 60,27 60,50 58,58 60,04 -0,45% 3,19% 1.313.900
09/10/2025 60,79 61,38 59,43 60,31 -0,84% 3,21% 1.320.100
08/10/2025 60,72 61,48 59,64 60,82 +1,08% 3,03% 1.663.600
07/10/2025 60,56 61,19 58,74 60,17 -0,78% 4,05% 1.784.900